The uptake and retention in a 2 cm thick brain section was recorded serially by SPECT after i. v. injec tion of [99mTc]-d,I-HM-PAO (HM-PAO). In 16 patients, the fraction of the administered dose retained by the brain was 5.2 ± 1%, showing a peak after 4�50s, then decreas ing by 10% within the first 10 min and then by only 0.4% per hour. The image contrast was measured in each pa tient as the regional hemispheric asymmetry difference in percent of the highest value of the two regions. It de ceased from 31 % at 3�0 s to 25% at 10 min. At 24 h, a value of 19% was reached. Using the images obtained at 10 min after injection, a region to region comparison of the original and corrected HM-PAO images to the x<!non-133 regional cerebral blood flow (rCBF) images was per formed, Forty-four patients with stroke, epilepsy, demen tia, basal ganglia disease, and tumors and control subjects were included in this comparison. The algorithm pro posed by Lassen et al. was used to correct the original images for back diffusion of tracer (brain to blood); a good correlation very close to the line of identity between the corrected HM-PAO and xenon-133 data was obtained when using a conversion/clearance ratio of 1.5 and when Hexamethylpropyleneamine oxime chelated with technetium-99m, i.e., [99ffiTc]-d,I-HM-PAO, has been introduced as a tracer of cerebral blood flow (CBF) (Leonard et at., 1986; .
Summary:
The uptake and retention in a 2 cm thick brain section was recorded serially by SPECT after i. v. injec tion of [99mTc]-d,I-HM-PAO (HM-PAO). In 16 patients, the fraction of the administered dose retained by the brain was 5.2 ± 1%, showing a peak after 4�50s, then decreas ing by 10% within the first 10 min and then by only 0.4% per hour. The image contrast was measured in each pa tient as the regional hemispheric asymmetry difference in percent of the highest value of the two regions. It de ceased from 31 % at 3�0 s to 25% at 10 min. At 24 h, a value of 19% was reached. Using the images obtained at 10 min after injection, a region to region comparison of the original and corrected HM-PAO images to the x<!non-133 regional cerebral blood flow (rCBF) images was per formed, Forty-four patients with stroke, epilepsy, demen tia, basal ganglia disease, and tumors and control subjects were included in this comparison. The algorithm pro posed by Lassen et al. was used to correct the original images for back diffusion of tracer (brain to blood); a good correlation very close to the line of identity between the corrected HM-PAO and xenon-133 data was obtained when using a conversion/clearance ratio of 1.5 and when Hexamethylpropyleneamine oxime chelated with technetium-99m, i.e., [99ffiTc]-d,I-HM-PAO, has been introduced as a tracer of cerebral blood flow (CBF) (Leonard et at., 1986; .
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the noninvolved hemisphere was used as a reference re gion (r = 0.86, p < 0.0001). Serial arterial and cerebral venous blood sampling was performed over 10 min fol lowing i.v. injection of HM-PAO in six patients. An over all brain retention fraction of 0.37 ± 0.03 (mean ± SEM) was calculated from the data. An average CBF of 0.62 ± 0.12 mUg/min was determined on the basis of the Fick principle; this compared to a value of 0.59 ± 0.09 mU glmin (mean ± SEM) measured by the xenon-133 inhala tion method. The two sets of CBF values correlated lin early with a correlation coefficient of 0.97 (p < 0.01). Inserting the average CBF value for the hemisphere as measured by the Fick principle into the algorithm de scribed by Lassen et al. yields absolute rCBF values (mil glmin) directly from the corrected HM-PAO images. We conclude that the xenon-133 inhalation method and [99mTc]-d,i-HM-PAO may supplement each other for SPECT studies of rCBF: xenon-133 inhalation for easy, repeatable, and quantitative measurements and This lipophilic tracer has an extraction across the blood-brain barrier of about 0.75 (Andersen et at., 1988a) . Inside the brain, it is rapidly converted to a hydrophilic form that is retained for many hours (Sharp et at., 1986) . However, the tracer complex is not trapped instantly after crossing the blood-brain barrier and therefore a significant degree of back diffusion from brain tissue to the blood takes place. This has been clearly shown in human studies re cording the total brain counts after intracarotid in jection of the tracer . In these studies, the total hemispheric counts reached a peak within seconds and then declined exponen tially to a steady-state level after about 10 min and represents about 40--50% of peak activity that was reached. To explain this, we proposed a compart mental model and a correction algorithm to account for incomplete retention of the tracer.
Due to incomplete extraction and to backdiffu sion, HM-PAO does not behave as a perfect "chemical microsphere" for measurements of CBF. Both processes imply that the retention of supplied tracer is not 100% as required for calculat ing CBF according to the bolus distribution princi ple of Sapirstein (1958) . The present paper de scribes two approaches for quantification of CBF by HM-PAO using single photon emission com puted tomography (SPECT) and correcting for in complete retention in the brain. The first is based on a kinetic analysis to correct for the variations of the regional fractional retention as described by Lassen et al. (1988) . The second is based on measurements of whole brain retention using the Fick principle. The validity of the two approaches for CBF quan tification has been evaluated by a comparison to CBF values obtained in the same patients with xe non-133 and SPECT.
MATERIAL AND METHODS

Tracers
[99mTc]-d,I-HM-PAO was produced by mixing fresh (less than 2 h old) eluate of [99mTc]-pertechnetate taken from a standard generator in daily use with 0.5 mg of freeze-dried d,l-HM-PAO in the vial supplied commer cially from Amersham International PLC (London, En gland). The fraction of the tracer complex that was li pophilic in the injectate was measured by paper chroma tography as described by Neirinckx et aI. (1987) . A value of 88 ± 3% was found. A bolus of [99mTc]-d,I-HM-PAO with 0.4-1.3 GBq in 8 ml was injected i.v.
Xenon-133 was inhaled from a 4 L bag in a closed sys tem for 1.5 min. During this time, the lung concentration reaches a maximum of 370 MBq/L at equilibrium (10 mCilL).
Patients
Forty-four patients with stroke, epilepsy, dementia, basal ganglia disease, and tumors and control subjects participated in the region to region comparison of cor rected HM-PAO images to xenon-133 regional cerebral blood flow (rCBF) images (Table O. Six patients were included in the study of whole brain retention of HM-PAO using the Fick principle: One nor mal volunteer (case 124), four patients with normal pres sure hydrocephalus (NPH) (cases 91, 97, 110, and 138), and one with hydrocephalus associated with increased intracranial pressure (IIPH) (case 137) were studied. Pa tient data are given in Table 2 . It is seen from Evan's ratios (Evan, 1942) that the ventricular systems were only slightly enlarged in the patients.
Informed consent was obtained according to the prin ciples of the Declaration of Helsinki II.
The tomographic study
The brain uptake was measured by the Tomomatic 64, a rapidly rotating, highly sensitive instrument for single photon emission tomography (Celsis et aI., 1981; Stokely et aI., 1980) . It consists of four detector arrays rotating close to the patients' head. One rotation takes 10 s. Three 1988 slices of brain tissue are studied simultaneously with 4 em between slice midplanes. The slices are routinely posi tioned 1, 5, and 9 em or 3, 7, and 11 em above the orbi tomeatal (OM) plane. The positioning of the head was controlled by a light positioning system using several ink dots on the skin. The tomographic images are recon structed using a filtered backprojection algorithm on the basis of 400,000 counts or more per slice.
For [99mTc]_d,I_HM_PAO, the axial and image plane resolution is 16-20 mm using the high sensitivity/low res olution collimator. The common acquisition schedule was 6 periods of 10 s followed by 12 periods of 1 min. In 16 of the patients, later studies were performed to follow the later time course of the retention of HM-PAO (Table 1) . A high resolution study (HRS) was performed in most of the patients beginning after 30 min.
In all patients, CBF was measured twice using the xe non-133 inhalation method and SPECT. Six contiguous slices were obtained situated at the levels of OM + 1, 3, 5, 7, 9, and 11 cm. The calculation of flow was based on a sequence of four xenon-133 distribution images (Celsis et aI., 1981; Kanno and Lassen, 1979; Stokely et aI., 1980) . The axial and image plane resolution for xenon-133 was 16 to 20 mm full width at half-maximum (FWHM). The arterial input curve of xenon-133 was estimated from a single, narrowly collimated NaI detector placed over the upper part of the right lung.
The comparison was carried out on the [99mTc]_ d,l-HM-PAO images obtained after 10 min and the xenon-133 image obtained about 1 h earlier using the same po sitioning and the brain slice situated about the OM + 5 em plane.
The same high sensitivity /low resolution collimator was used for both tracers. It has a sensitivity to 99mTc of 960 cps/LlMGq using a cylindrical 20 em in diameter water filled Perspex phantom and a 20% symmetrical window around the energy peak. The xenon-133 sensitivity is 380 cps/LlMBq.
Using the high resolution collimator, 99mTc sensitivity of 132 cps/LlMBq was obtained with a slice thickness of 9-10 mm. It could not be used for xenon-133 studies.
Procedure for quantification of regional CBF in relative units using the correction algorithm of Lassen et al. (1988) The 44 subjects studied included the 16 patients de scribed in more detail below. The gray/white matter ratio was studied in five of the patients having no focal. Quantification of regional CBF in the relative units of percent of a reference region was carried out using the algorithm of Lassen et aI. (1988) :
where C is the count rate and F the flow value per pixel of the brain region studied, and Cr the count rate and Fr the flow value of the reference region (cerebellum or whole brain). Ur is the conversion/clearance ratio of the reference region. Fr and Ur can be measured directly us ing the Fick principle as described below if the whole brain is selected as the reference region. We used Ur val ues of 1.2, 1.5, and 2.0 to find the best agreement of the corrected HM-PAO image of CBF studied by xenon-133 tomography. These Ur values were selected on the basis of a pilot study (data not shown) and the study of Lassen et al. (1988) , which indicated that the "true" ar was in the range of 1.0 to 2.0. The reference region used for normalization included both the cerebellar hemispheres and the mean counting rate of the middle brain slice (OM + 5 cm). Five regions of interest (ROI) were selected per patient were based on visual inspection guided by comparable CT scans. Each of the five ROIs included at least 100 pixels in the image field (64 x 64 matrix): (a) the highest activity in the region of the Sylvian fissure, (b) the visual cortex, (c) the sub cortical frontal region white matter, (d) a region contain ing the lowest activity (the ischemia region in patients with cerebrovascular disease; in the remainder, the re gion over the anterior horn of the lateral ventricles was chosen), and (e) the average value for the whole hemi sphere. The xenon-l33 CBF values were obtained for the same ROIs and were expressed as the percent of the cer ebellar mean value and as the percent of the mean value of the slice similar to that described above for HM -P AO. A direct comparison of the HM-PAO and xenon-l33 val ues were made by standard linear regression analysis.
In all cases, the analysis involved the HM-PAO image obtained over 1 min of acquisition 10 min after the injec tion of the tracer. It was essential to determine if the HM-PAO image remained constant with respect to distri bution pattern of radioactivity over longer periods since most clinical procedures will employ longer acquisition times. The stability of the [99ffiTc]-d,I-HM-PAO image Evan's ratio: a measure of the size of the ventricles that has been applied for CT scans (Evan, 1942) .
over time was studied in 16 of the 44 patients. The time course of total brain radioactivity was analyzed for I h in 16 patients and in 6 of these a repeat scan was obtained at 24 h (see Table 1 ). The HM-PAO counting rate was cal culated over the lesion, C(1), and over a region of equiv alent size situated symmetrically with respect to the mid sagittal plane in the opposite hemisphere, C(O), in 14 of the patients, a value representing the "contrast" of the image could be calculated; the "contrast ratio" (CR) is defined as (in %)
Two patients had tension headache and no focal lesion. In these subjects, CR was calculated as the difference between gray and white matter taken in percent of the value obtained in gray matter; it was calculated by placing a ROI over the occipital visual cortex and over the ante rior horn at OM + 5 cm. Five patients had defects of the blood-brain barrier in the lesions observed (Table 1 ).
In all of the above studies, we used the low resolution collimator, allowing short acquisition times. In addition, we evaluated the contrast between the gray and white matter retention using the high resolution collimator that required a 30 min acquisition time.
Procedure for measurement of whole brain retention and calculation of CBF using Fick's principle with HM-PAO In the six patients studied, the percutaneous punctures were made using the Seldinger technique (Se1dinger, 1953) , and a small polyethylene catheter (external diam eter of 1.2 mm) was introduced into the radial artery of the nondominant hand. Another catheter (external diam eter of 1.7 mm) was placed in the jugular bulb via punc ture low on the neck. The catheters were connected to stopcocks in a sampling machine and frequently flushed with heparin saline (4 i.u./mO. After i.v. bolus injection, 40 1 ml samples were obtained simultaneously from both catheters with 3 s intervals beginning 14 s after injection in the contralateral cubital vein. Further 1 ml samples were drawn manually after 3, 4, 6, 8, and 10 min. All samples were immediately placed into small, freshly hep arinized vials containing 2 ml of octanol, and the vials were shaken for 2 min. Analysis of the lipophilic fraction with correction for the slight extraction of the hydrophilic reaction products and contaminants was performed as previously described (Andersen et a\., 1988b) . The reten tion R was calculated for the curves for the first 10 min 1988 according to Eq. (2). The blood samples were analyzed in a well-type gamma counter (Packard autogamma 5385, Packard Instrument Co., Downer's Grove, IL, U.S.A.).
The calibration of brain and blood counts was deter mined in each study. A phantom was prepared from an empty human cranium filled with a plastic bag containing about 70 MBq of 99mTc. It was scanned with the same positioning and energy windows as used for the clinical study in each patient. Triple samples from the plastic bag were counted in the well counter together with the blood samples from the patient. The counting rates from large regions of interest in the brain slice situated 5 cm above the orbitomeatal plane were determined in the SPECT images obtained from the phantom. No significant differ ences were seen when centrally and peripherally located regions were compared.
Calculations
Noting that both the arterial (Cal) and cerebral venous (CvI) curves of the lipophilic tracer reached practically zero already after a few minutes, the fractional retention R at the steady state could be calculated by integration to 10 min:
(3)
With the assumption that this value is valid for the slice selected for the study, CBF could be calculated using the bolus distribution principle as modified for the case of incomplete retention:
where C is the average counting rate in the brain slice studied. Inserting Eq. (3) into Eq. (4), it is seen that this approach is equivalent to the application of the direct Fick principle on the slice selected, assuming that the sampled cerebral venous blood is representative of that from the slice. The image obtained from 9.5 to 10.5 min after injection was used and compared to the xenon-133 blood flow measurement of the same brain slice.
PC02 was measured in arterial blood using a conven tional electrode and in the end-expiratory air using an infrared capnograph. The xenon-133 CBF values were corrected to the same PC02 as recorded during the [99mTc]-d,I-HM-PAO studies using a correcting factor of 4% per mm Hg (Olesen et aI., 1971) .
The conversion/clearance ratio Ur for the whole brain was calculated from Ur = R/(E -R) (Lassen et aI., 1988) ,
where E is the apparent first-pass extraction of HM-PAO. E was as calculated from the cerebral blood flow F, de termined on the basis of the Fick principle [Eqs.
( 3) and (4)], and the linear equation described the empirical rela tionship between whole-brain blood flow and E described previously by Andersen et al. (1988a) : E = -0.37F + 0.90.
RESULTS
The stability of the tracer in the brain
The stability of total hemispheric and regional HM-PAO activity over time was determined follow ing i.v. injection of [99ffiTc]-d,I-HM-PAO. The max imal counting rate over the head was recorded in the tomograms taken 40 to 50 s after the injection using 10 s acquisition frames ( Fig. O. Thereafter, the counting rates fell reaching 90 ± 2% (mean ± SEM) of the maximum after 10 min. This value cor responded to 5.2 ± 1.0% of the injected dose of tracer assuming a brain weight of 1300 g. Over the following 24 h, the decay-corrected counts fell by a further 10% of the initial peak value.
It is important to note that the contrast between lesion and contralateral brain tissue remained es-sentially unchanged for several hours (Fig. 2) , even in patients with hyperperfusion, blood-brain barrier defect, and stroke. The change in contrast [CR ratio in Eq. (2)] between high and low HM-PAO activity regions in the brain over time is presented in Table  3 . The CR ratio decreased substantially over the first 3 min after i. v. injection of [ 99 rnTc ]-d, 1-HM-PAO and became quite stable between 10 min and 2 h. Similar observations were made with re gard to the gray/white matter ratio. Using the low resolution collimator, the gray/white matter activity ratio declined from 1.4 ± 0.2 at 30 to 40 s postin jection to 1.2 ± 0.1 at 10 min. Mter correction with Ur = 1.5, the 10 min gray/white matter ratio aver aged 1.9 ± 0.3. Using the high resolution collima tor, the gray/white matter ratio was 1.7 ± 0.2 before and 2.3 ± 0.2 after the correction.
A detailed quantitative region to region compar ison was performed on data from 44 patients. Using a cerebellar or cerebral hemisphere as the reference region and three different a values, a measured count rate ratio ClCr was obtained and corrected using the algorithm of Lassen et al. (1988) to yield a P/Pr ratio (Fig. 1) . The C/Cr ratio and the P/Pr ratio are plotted vs. CBF measured with xenon-133 in corresponding brain regions ( Figs. 3a and 3b , re spectively) and the coefficient of the linear correla tion for different values of Ur in the two reference regions are presented in Table 4 indicates that an ar value of 1.5 yields a plot of F/Fr vs. CBP that approximates the line of identity (Pig. 3b). In addition, the correlation coefficients of the plots were higher when using the cerebral hemi sphere as the reference region. Subdividing the 44 patients into six clinical subgroups showed practi cally the same results. In all groups, a = 1.5 gave a correlation line closer to the line of identity than the uncorrected data. The effect of this correction is shown in Pigs. 4a-d.
CBP quantitation using the fick principle
In six patients, the arterial and jugular venous blood concentration of [ 99 ffiTc]-d,l-HM-PAO was measured sequentially after i. v. administration and blood flow was calculated on the basis of the Pick principle. The arterial input concentration of [ 99 ffiTc]-d,l-HM-PAO to the brain was larger than the venous outflow concentration, resulting in a net brain uptake during the first minute (Pigs. 5a, b). Between 1 and 2.5 min, the venous outflow concen tration was significantly in excess of the arterial concentration. After 2.5 to 3 min, the arterial input and venous concentration are about the same. Us ing these data, total brain steady-state retention was calculated [Eq. (3)]; an average value of 0.37 ± 0.07 (mean ± SD) was obtained (Table 5 ). Correcting the count rate of the middle brain slice for incomplete retention gave a mean CBP for the slice of 0.62 ± 0.12 mllg/min, whereas a value of 0.59 ± 0.9 mIl g/min was found with xenon-133 (Table 6 ). The val ues of CBP determined from the [ 99 ffiTc]_d,l_ HM-PAO data and Eq. (4) in the six patients corre lated well with the pC02 corrected xenon-133 val ues (r = 0.97, p < 0.01; Pig. 6), although the slope differed from unity and the intercept did not pass through the origin. The correlation remained high even without the pC02 correction (r = 0.92 and p < 0.01). The conversion/clearance ratio a was ob tained from the arterial and venous blood sampling data; a value of 1.3 ± 0.3 (mean ± SD) was obtained (Table 5) . Sharp et al. (1986) and Leonard et al. (1986) and confirms that brain activity reaches a peak value 40-60 s after i. v. injection and then de- clines about 10% within the first 10 min. A prefer ential loss from the high flow regions is suggested since the gray/white matter ratios declined from 1.4 to 1.2 during the first 10 min after injection. A mod erate decrease in contrast also occurs in the various disease states that were studied. In the compartmental model developed by Las sen et al. (1988) , complete fixation of e9ffiTc]_ d,l-HM-PAO in the brain is assumed after the first few minutes. Brain activity of 24 h showed only a small further decrease, reaching about 90% of the value measured at 10 min. This slow release and loss of radioactivity was taking place at the rate of 0.4% per hour. The contrast ratio [Eq.
(2)] also de creases over 24 h to about 75% of its steady-state value at 10 min. No major exceptions were seen to this average course, not even in those patients in the hyperemic phase following ischemic infarction or with blood-brain barrier lesions. Sporadic cases with hyperperfusion have been reported to show a faster decrease of contrast (Holmes et aI., 1987) . In this case, the loss of [ 99 ffiTc]-d,I-HM-PAO from the hyperemic brain region is evident after 3 to 6 h. The practical consequences of this observation is that the data acquisition should be completed within 1 to 2 h after injection of the tracer.
Intravascular [99mTc ]-d,l-HM-PAO
The images of [ 99 ffiTc]-d,I-HM-PAO distribution in the brain includes the measurement of counts in the vascular bed as well as in the tissue proper. Only the lipophilic form of the tracer is taken up by the brain in measurable amounts. As reported by Andersen et al. (1988b) , blood samples at steady state (10 min) has a tracer concentration of about 2.2 x 10-5 of the injectate. Assuming that 3% of the brain tissue is blood, the activity in the blood ves sels represents about 6.6 x 10-7 of the injectate activity per gram of brain. With a brain uptake of 5.2% of the injectate activity and a brain weight of 1300 g, the total tissue concentration at steady state is about 4.0 x 10-5 of the injectate activity per gram, i.e., almost 100 times greater than that of the blood compartment. Although anecdotal, this can also be concluded from the study of a patient with a massive arteriovenous malformation. The steady state image in this patient showed the malforma tion, a structure containing >90% blood, as a "cold" area. Table 1 ). The CT scan was normal. OM + 5 cm (a and b) and the OM + 7 cm (c and d) are given. The corrected images were obtained using Eq. (1) and Ct = 1.5 (Lassen et aI., 1988) . They are scaled to a cerebellar blood flow of 50 ml/100 g/min; the scale bar on the right side is color coded to a range of values in the same units. A higher contrast is achieved after correction but the overall information is almost the same in the two sets of images.
Validation of HM-PAO as a tracer for regional CBF
We used the xenon-133 inhalation method to measure regional CBF using SPECT. This measure ment is the "standard" for our comparison with [ 99 ffiTc]-d,I-HM-PAO. The [ 99 ffiTc ]-d,I-HM-PAO images agree quite well with the CBF images ob tained with xenon-133 even without using any cor rections. A slightly curvilinear relationship, deviat ing from the line of identity, was found experimen tally ( Fig. 3a) and is consistent with the model J Cereb Blood Flow Metab, Vol. 8, Suppl. 1, 1988 proposed by Lassen et a1. (1988) . However, when using the correction algorithm and a value of 1.5 for an a linear correlation close to the line of identity was obtained (Fig. 3b) . A similar result was ob tained using the correction algorithm on [ 99 ffiTc]_ d,l-HM-PAO SPECT data in three other studies (Y onekura et al., 1988; Inugami et al., 1988; Langen et aI., 1988) when CBF was measured by PET and oxygen-IS-labeled carbon dioxide (Table 7) .
The autoradiographic study in normal rats by Table 2 ). The net input to the brain (b) was obtained by subtracting the measured arterial and venous concentrations shown in a.
Lear using carbon-14-labeled iodoantipyrine for comparison to [99mTc]-d,I-HM-PAO also supports the validity of the correction procedure (Lear, 1988) . Five studies using three different reference techniques all concur in demonstrating the validity of the CBF technique using [99mTc]-d,I-HM-PAO in a total of 90 patients suffering from a variety of neurological diseases including stroke, tumors, de mentia, epilepsy, and headache. Thus far, no dis ease state has been reported where the CBF dependent retention of [99mTc]-d,I-HM-PAO can not be corrected by the algorithm proposed by Lassen et al. (1988) . R: retention after 10 min, E: apparant extraction. E = -0.37F + 0.90 (Andersen et a! ., 1988b) , where F is whole brain blood flow using HM-PAO calculated by the Fick principle (Table 6) . b Subtracting total venous counts from the total arterial counts, the corresponding value was 169 ± 67 x J04 counts .
Choice of a reference region
In the present study, we found the highest corre lation coefficient between [ 99 mTc]-d,I-HM-PAO and xenon-133 CBF measurements when the aver age count rate in the whole hemisphere was used as the reference for both techniques. With the cerebel lar hemispheres as reference, the correlation was not quite as good. This is due to the difficulties in accurately measuring cerebellar blood flow by the xenon-133 inhalation method. The cerebellum is seen in the plane showing the artifact due to xenon-133 gas in the airways. This tends to give more vari able CBF values and the value of CBF for the whole slice diminishes as the airway artefact becomes larger. The results of Inugami et al. (1988) are consistent with this interpretation; comparing [99mTc]-d,I-HM-PAO SPECT to oxygen-15 carbon b CBP values corrected to the pC02 of the HM-PAO study (Olesen et aI., 1971) . C This medical student was anxious during the HM-PAO study, but more relaxed during xenon-133 inhalation. All patients were at rest. dioxide PET found that the cerebellum gave prac tically the same results as the cerebral hemisphere when used as the reference brain region. The cere bellum may be a preferred region of reference in some specific disease states such as senile demen tia. In such patients, the cerebellum would cor rectly convey information of a reduced forebrain blood flow provided that the cerebellar flow is un- affected by the disease as the xenon-133 data ap pear to show.
Calculation of regional CBF in absolute units of mllg/min
The procedure discussed above yields CBP rela tive to a reference region. Using the Pick principle, we can calculate the average CBP in absolute units with HM-PAO. This approach, based on sampling arterial and cerebral venous blood, was used in six patients and a good agreement was found with and even without correction for the small changes in arterial pC02 (Table 6 ). The Pick principle used to estimate CBP in the present study is based on a simple mass balance consideration and a uniform brain mass. More assumptions are made using the xenon-133 method to measure CBP. Por example, xenon-133 delivery as a bolus and brain clearance principles are combined in one algorithm, taking the count rate over the lung to be proportional to the arterial input concentration (Celsis et aI., 1981; Kanno and Lassen, 1979; Stokely et aI., 1980) .
In order to calculate the regional CBP using the bolus distribution principle, it is necessary to know the regional fractional retention so as to satisfy the mass balance requirement of Pick's principle. Had this value been a constant fraction in all regions, then the HM-PAO distribution pattern would reflect CBP. By measuring R for the whole brain and thereby average CBP, we can "calibrate" rCBF in absolute units. This approach does have some prob lems, because of the difference in contrast between high and low flow regions measured by HM-PAO compared to xenon-133 and suggests a lower reten tion of HM-PAO in high flow regions. This obser vation underlies the development of the compart mental model by Lassen et ai. (1988) . It assumes (within any given patient) constancy from region to region of the partition coefficient (X,), the conver sion constant k3, and of the apparent blood-brain barrier extraction E. With these assumptions, where the absolute values of X,k3, k3, and E may vary from one patient to the next, it is solely the rate of blood flow that causes the preferential loss (lower fractional retention) in high flow regions. The results presented in this study show that HM-PAO distribution in brain corrected by the algorithm developed by Lassen et al. (1988) Table 2 ). The horizontal brain slice situated 6 cm above the orbitomeatal plane is shown. The study was performed with a low resolution collimator at 10 min after injection of 1 GBq of [99mTcj-d,l-HM-PAO. A: the actual image obtained after 10 min using a 1 min period of acquisition. A low-flow area is seen in the right hemisphere in the central and frontoparietal region. B: the image has been corrected for incomplete retention (Lassen et aI., 1988 ) using a value of 1.2 for cx (similar to the average value of the six patients in this study; Table 5 ). Note that the use of this value or the value of 1.63 determined experimentally for case 91 (C left) or the value of 2.0 (C right) gives very similar images. Most of the cerebral blood flow information is already present in the original image (A); the correction algorithm enhances the contrast between low and high flow regions (A compared to B). (b) A comparison of reBF measured with xenon-133 (left) and [99mTcj-d,I-HM-PAO in case #91 and for the same slice shown in a. Quantification of reBF in ml/g/min for the HM-PAO study was performed by using the whole brain as the reference region (cx, = 1.5) and the correction algorithm (Lassen et aI., 1988) . Whole brain blood flow (F,) was measured by the Fick principle. (c) A comparison of [99mTcj-d,I-HM-PAO images from case #91 at the level through the basal ganglia (4 cm above the orbitomeatal plane). Higher resolution (1.0 to 1.1 cm, FWHM) was achieved by a longer (30 min) scan period beginning 15 min after injection. The same sequence of corrections was applied to this higher resolution scan as described in a and a similar enhancement of contrast is seen. The low blood flow in the right thalamic region is best seen after the correction.
rCBF in absolute units if the average count rate of the brain is used as the reference. An example of using this approach is given in Figs. 7a-c. However, it is more practical to measure the average flow by the noninvasive xenon-133 technique to obtain the reference value for expressing flow in absolute units. Another approach to HM-PAO data analysis has been proposed that is based on regional curve fitting analysis of the brain uptake curves. Matsuda et al. (1988) used this approach to analyze a series of to mograms obtained over the first 10 min after i. v. injection of [ 99 mTc]-d,I-HM-PAO. Nimmon et al. (1988) has also proposed a curve-fitting approach to their sequential data of the total hemispheric activ ity counts obtained over a 10 min period using a nonrotating gamma camera. Neither of these stud ies include an experimental determination of the ac tual arterial concentration or input of lipophilic HM-PAO to the brain. In both studies, integration over many pixels had to be performed with a result ing decrease of spatial resolution. Using the quan tification procedure we propose, there is no loss of spatial resolution. The HM-PAO image corrected for incomplete retention reflects CBF with high res olution and contains in our opinion more informa tion than a low resolution image in absolute units of flow.
The comparison of [ 99 mTc]-d,I-HM-PAO as a tracer for CBF to xenon-133 and 0-15 using PET (Y onekura et aI., 1988; Inugami et aI., 1988; Langen et aI., 1988 ) provides a solid basis for the explora tion of its clinical value. As a functional imaging modality, CBF tomography is basically quite differ ent from the structure-related techniques, i.e., CT and MRI. With promising preliminary results in ce rebrovascular disease (Ell et aI., 1985) , dementia (Schmidt et aI., 1987) , and epilepsy (Podreka et aI., 1987) , it is evident that functional brain imaging in terms of CBF may be of considerable clinical use fulness. [ 99 mTc]-d,I-HM-PAO and SPECT provide a simple and yet reliable technique to achieve this goal.
[ 99 mTc]-d,I-HM-PAO provides the opportunity to extend CBF tomography on a wide and practical scale. The basic instrumentation is already at hand in many places. The short labeling period, essen tially lasting only 2 min, and the prolonged retention allow us to perform measurements hours later and to achieve high resolution images (9 to 11 mm FWHM in the image plane). With xenon-133 spe cialized SPECT instruments, a resolution on the or der of only about 16-20 mm (FWHM) has been ob tained. However, repeated studies with xenon-133 with an interval as short as 20 min can be per-J Cereb Blood Flow Metab, Vol. 8, Suppl. 1, 1988 formed. The lower radiation exposure and the abil ity to obtain CBF images in mllg/min are also ad vantageous features of xenon-133. However, SPECT imaging using [ 99 mTc]-d,I-HM-PAO does not have the inherent errors of the xenon method : the airway artefact and the poor resolution of deeper structures. Therefore, the two methods will probably supplement each other : xenon-133 inhala tion for easy, repeatable and quantitative measure ments and [ 99 mTc]-d,I-HM-PAO for high resolution static imaging in relative flow units.
